WHO seal: Covaxin may be missing the USFDA ballast

WHO experts to reconvene for final risk-benefit study on November 3

Comments

Popular posts from this blog

Congress groomed me not to sit at home: Shivakumar

Infosys lays off hundreds after failing internal assessments in Mysuru

K’taka police announce Rs 5 lakh reward for Bidar ATM guard, Afzalgunj shooters